Loading...

SIGA Technologies, Inc.

SIGA•NASDAQ
Healthcare
Drug Manufacturers - Specialty & Generic
$7.14
$0.08(1.13%)

SIGA Technologies, Inc. (SIGA) Company Profile & Overview

Explore SIGA Technologies, Inc.’s business operations, leadership, sector classification, and key company facts including IPO date, industry, and contact details.

SIGA Technologies, Inc. (SIGA) Company Profile & Overview

SIGA Technologies, Inc., a commercial-stage pharmaceutical company, focuses on the health security and infectious disease markets in the United States. Its lead product is TPOXX, an oral formulation antiviral drug for the treatment of human smallpox disease caused by variola virus. SIGA Technologies, Inc. has a strategic partnership with Cipla Therapeutics to deliver sustained innovation and access to antibacterial drugs primarily against biothreats. The company was incorporated in 1995 and is headquartered in New York, New York.

SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
CEODiem Nguyen

Contact Information

https://www.siga.com
212 672 9100
31 East 62nd Street, New York City, NY, 10065

Company Facts

46 Employees
IPO DateSep 10, 1997
CountryUS
Actively Trading

Frequently Asked Questions

;